NASDAQ: RNA       Avidity Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
26.98   +1.11 (4.29%)  25.50 - 28.56  78,083


Avg Volume (4 weeks):731,128
4 Weeks Range:25.50 - 35.00
4 Weeks Price Volatility (%):
52 Weeks Range:25.50 - 35.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. The Company's clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company's platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1896  3849  321  2998 

Top 10 Active Counters
 LK 1.38-1.62 
 NIO 8.923+1.013 
 WKHS 22.145+2.965 
 AVP 5.60-0.05 
 SOLO 3.14+0.81 
 AABA 19.630.00 
 AAL 12.705-0.105 
 TGE 22.39+0.81 
 SQQQ 7.108-0.182 
 APY 10.34+0.25 
Partners & Brokers